Optimizing Outpatient Care in Hematopoietic Cell Transplant Patients
Educating physicians and oncology nurses about the requirements and advantages of an outpatient HCT program would enable the implementation of this program in their institution and help identify appropriate patients who could benefit from this treatment approach.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Strategies to Reduce Clostridioides Difficile Infection in Hematologic Malignancies
A key component of managing patients with hematologic malignancies, especially those who are HCT recipients, lies in preventing, detecting, and treating C. diff infections by establishing C. diff screening procedures and the appropriate use of anti-infective therapy. Knowledge gained in this arena will support prevention, detection, and timely management of C. diff infections in patients with hematologic malignancies who are HCT recipients.
Category
  • Cancer-related Infections
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Management of Cardiac Complications in Hematologic Malignancies
Continued education for oncology care providers is necessary to promote awareness of the cardiac effects of hematologic malignancies and their treatment so that effective methods of management may be implemented.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Advances and Innovations in Multiple Myeloma
Health care providers managing the patients with multiple myeloma, including oncology nurses and advanced practice nurses, need to be aware of new information, including best treatment strategy, management of adverse effects and other supportive care measures, and transfer their learnings to patients and other members of the care team.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Establishing a Place in Therapy for Biosimilars in Oncology
Clinical oncology pharmacists have the opportunity to provide education on biosimilars and be a part of the multi-disciplinary decision-making process for incorporating biosimilars into practice sites. In addition, pharmacists will need training on reporting post-marketing surveillance data regarding immunogenicity, product variability and drift of biosimilars as use becomes widespread.
Category
  • Biosimilars
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Advances in Acute Myeloid Leukemia (AML) Management: Focus on Secondary AML and Older Patients with AML
Clinicians need to be informed about therapeutic advances and necessary supportive care precautions to aid in their efficacious and safe incorporation into clinical practice for the appropriate AML patient subpopulations. 
Category
  • Acute Myelogenous Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Treatment Advances for Pediatric B-Cell Non-Hodgkin's Lymphomas
This is a potentially curable malignancy and systemic therapy is the mainstay of treatment. Understanding the diagnosis, workup, and subsequent treatment for early stage and later stage disease will improve understanding and subsequently, education for patients and caregivers alike.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the New NCCN Guidelines for Pediatric Cancers: Key Considerations for the Management of Pediatric Hodgkin Lymphoma
The NCCN Guidelines for pediatric Hodgkin lymphoma were created to help define optimal clinical care for these patients. Continuing education on emerging developments in this arena will help ensure that clinicians are aware of how best to incorporate these strategies, which may enhance care and outcomes for patients with pediatric Hodgkin lymphoma.
Category
  • Hodgkin Lymphoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Emerging Strategies in the Treatment of Venous Thromboembolism
Expanded indications for the use of the direct oral anticoagulants demand diligent monitoring. Health care professionals play a crucial role in the management of anticoagulation in cancer patients and anticoagulation monitoring clinics may need to rechannel resources to include these agents.
Category
  • Venous Thromboembolic Disease
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Gastric Cancer
Clinicians must consider disease stage, histology, biomarker expression and patient performance status to make decisions regarding optimal care. In addition, clinicians should regularly evaluate recent clinical trial data to make informed decisions on the most appropriate treatment plan, particularly as new targeted therapies become available.
Category
  • Gastric/Esophageal Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation

Pages